
Ebola Vaccine Study Finds Cross-Reactive T Cells Against Bundibugyo Virus
An Ebola vaccine study reports cross-reactive T cells against Bundibugyo virus as the outbreak in Congo continues.

An Ebola vaccine study reports cross-reactive T cells against Bundibugyo virus as the outbreak in Congo continues.

GLP-1 drugs were linked to lower psychiatric acute care in patients with schizophrenia and type 2 diabetes, BMJ reports.

UKRI’s £90 million MRC programme will support 600 future medical researchers across the UK through new doctoral awards.

MRC reopens curiosity-driven research funding as UKRI launches new autumn calls across discovery science and clinical research.

Nature Medicine reports an early randomized trial of inhaled siRNA targeting RAGE for pulmonary inflammation.

A new study says pathology should be embedded early in cancer trial design to improve feasibility and trial quality.

New BMJ research explores intravenous iron before cardiac surgery and what it could mean for pre-operative anaemia care.

Paxlovid did not improve Long COVID symptoms in a large NIH-funded trial published in Lancet Infectious Diseases.

Mayo Clinic researchers report a new strategy that may help CAR-T therapy work better against thyroid cancer.

Protein-proximity therapies are advancing after the first approved PROTAC for breast cancer, signaling a new phase in precision medicine.

Researchers identify activated dendritic cells as key to anti-cancer immunity, opening new possibilities for immunotherapy.

England is rolling out precision radiotherapy for prostate cancer, cutting treatment sessions from 20 to five.